Company / Operating Margin
Eton Pharmaceuticals, Inc. Operating Margin History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-3.8%
FY2025
5-year range
-69515.4% / -3.8%
FY2021-FY2025
Trend
+90.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin has fluctuated over the past 7 years, ranging from -69515.4% in FY2022 to -3.8% in FY2025.
Based on SEC 10-K filings.
-3.8% in FY2025 with a 5-year CAGR of +1072.5%.
Improved from -6.9% to -3.8% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +69511.6pp
- 5-Year Change
- +1072.5pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin increased 90.3% year-over-year.
- Lowest operating margin in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -3.8% | +90.3% |
| FY2024 | -38.9% | -467.4% |
| FY2023 | -6.9% | +100.0% |
| FY2022 | -69515.4% | -3484.0% |
| FY2021 | -1939.6% | -80.2% |
| FY2020 | -1076.2% | +24.7% |
| FY2019 | -1430.0% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026